Schering to buy NeoGenesis
238458
Seeking to improve its drug discovery technology and establish a beachhead in the fertile Cambridge biotechnology cluster, drug giant Schering-Plough Corp. of Kenilworth, N.J., said it would buy NeoGenesis Pharmaceuticals Inc. of Cambridge for an undisclosed sum.
411592
It makes sense for the drugmaker to sell millions more shares right now.
349840
Pfizer Inc. PFE.N is close to an  agreement to buy Angiosyn Inc., a biotech start-up working on a  drug to ward off blindness, in a deal potentially valued at  $527 million, the Wall Street Journal reported on Thursday,  citing people familiar with the situation.
356950
Consolidation in Europe's drugs   sector gathered steam on Thursday as Germany's Merck unveiled a   $13.3-billion deal to buy Europe's top biotech firm Serono, and   Denmark's Nycomed won the drugs unit of Altana.
532662
Gilead Sciences Inc. , a leading producer of HIV drugs, said yesterday it plans to acquire biotech firm Myogen Inc. for about $2.5 billion in cash, signaling a surprising expansion into treatments for pulmonary diseases.
531621
Schering gets an expanded label and begins marketing another drug overseas.
457209
Akzo Nobel  said on Monday it was selling its drugs unit Organon BioSciences to Schering-Plough  for 11 billion euros ($14.4 billion), in a last-minute reversal of plans to float it on the stock market.
70285
Akzo Nobel  said on Monday it was selling its drugs unit Organon BioSciences to Schering-Plough for 11 billion euros ($14.5 billion), dropping plans to float it in a public share offering.
620527
Dutch-Swedish pharmaceutical group Akzo Nobel said on Monday that it had agreed to sell its Organon BioSciences drugs unit to US rival Schering-Plough for 11 billion euros (14.4 billion dollars).
445972
Pfizer Inc. has agreed to license a  set of potential drugs for the prevention of stroke and heart  attacks from Germany's Schering, the two companies said on  Wednesday.
582652
Roche Holding AG, the world's biggest maker of diagnostic tests, offered to buy Ventana Medical Systems Inc. for about $3 billion as it expands screening to match patients with the right drugs.
485519
FRANKFURT/LONDON  - German drug maker Schering has   entered into a deal with AstraZeneca to jointly develop a new   breast cancer drug, the companies said on Friday.
220351
Shares of ViroPharma (VPHM:Nasdaq - news - research) were among the best-performing health and pharmaceutical stocks Monday after Schering-Plough (SGP:NYSE - news - research) said it would pay $10 million to license ViroPharma&#39;s cold drug.
633530
Schering-Plough Corp.  is  seriously considering approaching Bristol-Myers Squibb Co.   about a possible merger, according to a report in The  Star-Ledger newspaper on Friday.
627268
By Sharon Smyth  Merck, the German pharmaceutical company that failed to buy a rival, Schering, this year, agreed to buy the stake owned by the billionaire Ernesto Bertarelli in Serono to obtain control of the largest biotechnology company in Europe.
738544
The cancer diagnostic equipment maker is expected to announce that it will acquire Spring Bioscience, a developer of antibodies, for $28.9 million in cash.
583185
Consolidation in Europe's drugs  sector gathered steam on Thursday as Germany's Merck unveiled a  $13.3-billion deal to buy Europe's top biotech firm Serono, and  Denmark's Nycomed won the drugs unit of Altana.